Glycemic Control
Glycemic Control is a clinical management strategy within metabolic medicine that involves the systematic regulation of blood glucose levels to maintain them within a target range, distinguishing it from broader diabetes management by focusing specifically on the modulation of hyperglycemia and hypoglycemia to optimize patient outcomes in perioperative, critical, and chronic care settings.
42.7K
Publications
2.9M
Citations
138.3K
Authors
14.3K
Institutions
Publications per year
2017–2026
10.8K
Variants
Glycaemic Control
42.7K
1–5 of 42.7K
138.3K
100
h-index
92
h-index
University of North Carolina at Chapel Hill, United States
163 publications · 53.9K citations
82
h-index
75
h-index
73
h-index
1–5 of 138.3K
14.3K
Harvard University
Cambridge, United States
159 h-index
2.3K publications
259.2K citations

University of Toronto
Toronto, Canada
137 h-index
1.7K publications
192.9K citations
Yale University
New Haven, United States
130 h-index
1.5K publications
218.3K citations

Novo Nordisk (Denmark)
Copenhagen, Denmark
126 h-index
1.5K publications
178.3K citations
University of Washington
Seattle, United States
123 h-index
1.3K publications
138K citations
University of Copenhagen
Copenhagen, Denmark
114 h-index
2.1K publications
162.8K citations

Joslin Diabetes Center
Boston, United States
111 h-index
1.1K publications
111.7K citations
Eli Lilly (United States)
Indianapolis, United States
108 h-index
1.8K publications
213.5K citations
1–8 of 14.3K
3.1K publications · 414.7K citations
293
h-index
1.6K publications · 157.5K citations
196
h-index
906 publications · 93.5K citations
146
h-index
NEJM · 238 publications · 192.4K citations
142
h-index
JCEM · 932 publications · 78.5K citations
132
h-index
1–5